We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+10.89%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$36.2B
AUM Growth
+$2.03B
(+6%)
Cap. Flow
-$1.03B
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
14.34%
Holding
2,349
New
214
Increased
749
Reduced
1,086
Closed
196
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$165M |
| 2 |
American Electric Power
AEP
|
+$143M |
| 3 |
Duke Energy
DUK
|
+$123M |
| 4 |
Medtronic
MDT
|
+$121M |
| 5 |
Eli Lilly
LLY
|
+$86.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$211M |
| 2 |
Chevron
CVX
|
+$186M |
| 3 |
STOR
STORE Capital Corporation
STOR
|
+$172M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$169M |
| 5 |
ExxonMobil
XOM
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.91% |
| 2 | Financials | 14.92% |
| 3 | Technology | 12.39% |
| 4 | Consumer Discretionary | 8.32% |
| 5 | Consumer Staples | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
TG Therapeutics
TGTX
$8.12B
| $6.92K | ﹤0.01% |
585
-581,836
| -100% | -$4.22M |
|
|
CHS
1902
DELISTED
Chicos FAS, Inc.
CHS
| $6.84K | ﹤0.01% |
1,390
+1,038
| +295% | +$5.84K |
|
1903
Asbury Automotive
ABG
$3.68B
| $6.63K | ﹤0.01% |
+37
| New | +$6.19K |
|
1904
Five Star Bancorp
FSBC
$1.12B
| $6.21K | ﹤0.01% |
228
-12
| -5% | -$336 |
|
1905
Elastic
ESTC
$8.94B
| $6.18K | ﹤0.01% |
+120
| New | +$7.19K |
|
1906
Quad
QUAD
$492M
| $5.98K | ﹤0.01% |
1,465
-57
| -4% | -$181 |
|
1907
Sanmina
SANM
$10.3B
| $5.96K | ﹤0.01% |
104
+30
| +41% | +$1.77K |
|
1908
Unitil
UTL
$951M
| $5.96K | ﹤0.01% |
+116
| New | +$5.9K |
|
1909
Personalis
PSNL
$1.72B
| $5.87K | ﹤0.01% |
2,966
+1,391
| +88% | +$3.5K |
|
1910
Medifast
MED
$134M
| $5.77K | ﹤0.01% |
50
-24
| -32% | -$2.79K |
|
1911
BlackSky Technology
BKSY
$875M
| $5.76K | ﹤0.01% |
467
+322
| +222% | +$4.29K |
|
1912
CRH
CRH
$58.3B
| $5.73K | ﹤0.01% |
144
-10
| -6% | -$374 |
|
1913
CytomX Therapeutics
CTMX
$586M
| $5.67K | ﹤0.01% |
3,542
-715
| -17% | -$1.06K |
|
1914
BeyondSpring
BYSI
$30.9M
| $5.63K | ﹤0.01% |
2,994
-947
| -24% | -$894 |
|
1915
The GEO Group
GEO
$4.11B
| $5.58K | ﹤0.01% |
+510
| New | +$4.96K |
|
1916
Digi International
DGII
$2.6B
| $5.45K | ﹤0.01% |
149
-240
| -62% | -$9.24K |
|
1917
Orrstown Financial Services
ORRF
$838M
| $5.44K | ﹤0.01% |
235
+141
| +150% | +$3.6K |
|
1918
AMC Entertainment Holdings
AMC
$2.28B
| $5.37K | ﹤0.01% |
132
-8
| -6% | -$504 |
|
1919
Bioventus
BVS
$888M
| $5.3K | ﹤0.01% |
+2,029
| New | +$8.86K |
|
1920
Weis Markets
WMK
$1.78B
| $5.27K | ﹤0.01% |
+64
| New | +$5.4K |
|
1921
Bolt Biotherapeutics
BOLT
$7.76M
| $5.24K | ﹤0.01% |
201
+94
| +88% | +$2.58K |
|
1922
UFP Technologies
UFPT
$2.13B
| $5.19K | ﹤0.01% |
44
-25
| -36% | -$2.67K |
|
|
TECX
1923
Tectonic Therapeutic
TECX
$557M
| $5.12K | ﹤0.01% |
598
-197
| -25% | -$1.73K |
|
1924
Trinity Industries
TRN
$2.24B
| $4.97K | ﹤0.01% |
168
| – | – |
|
1925
iShares MSCI Japan Value ETF
EWJV
$788M
| $4.94K | ﹤0.01% |
202
-23
| -10% | -$535 |
|
Similar funds
Federated Hermes's Q4 2022 Portfolio in Review
As of Q4 2022, Federated Hermes held 2,349 positions worth $36.2B, up 6% from $34.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Federated Hermes's Q4 2022 filing shows 214 new, 749 increased, 1,086 reduced and 196 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M. The largest sale was Amgen, an estimated $211M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M.
- Federated Hermes added most to LyondellBasell Industries in Q4 2022, an estimated $165M increase.
- Federated Hermes's biggest Q4 2022 reduction was Amgen, cutting an estimated $211M.
- Federated Hermes fully exited Akouos Inc in Q4 2022, selling an estimated $27M.
- Federated Hermes's ten largest holdings make up 14% of its $36.2B portfolio in Q4 2022.
- Federated Hermes opened 214 new positions and closed 196 in Q4 2022.
- Federated Hermes's portfolio value rose 6% quarter-over-quarter to $36.2B.
Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.